Caplight Directory>Companies>CoBX Bio-preview>Cobxbio


CoBX Bio

CoBX Bio

Private
SeoulHealthcare & Life Scienceshttps://cobxbio.com/

Last Round

Pre Seed

Sep 3, 2025

Total Funding Raised

$5.55M

Company Overview

CoBX Bio, Inc. is a pharmaceuticals company that researches and develops covalent bond inhibitors and molecular adhesive degraders to address shortcomings of current synthetic medications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

covalent inhibitorsmolecular adhesive degradersAI drug discoverymolecular gluestargeted protein degradationAI biotechprotein degradersundruggable targetssmall molecule discoverydrug discovery platformoncology therapeuticschemical proteomicspreclinical biotechnologydrug licensingMenin inhibitorGSPT1 degrader

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CoBX Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CoBX Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 3, 2025
View all Funding Rounds

CoBX Bio Investors

Notable investors and investment history

InvestorRounds
UTC InvestmentPre Seed
Korea Investment PartnersPre Seed
KB InvestmentPre Seed
Company K PartnersPre Seed
Laplace PartnersPre Seed
Solidus InvestmentPre Seed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 3, 2025

    $5.55M raised from UTC Investment and Company K Partners.

View all signals

CoBX Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CoBX Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CoBX Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Year Founded2024
Last FundingSep 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.